Erba Diagnostics, Inc. reported Revenue increase of 13.66% year on year in the first quarter 2014, to $ 4.85 millions, this is lower than Erba Diagnostics, Inc.'s recent average Revenue increase of 14.33%.
Looking into first quarter 2014 results within Laboratory Analytical Instruments industry 21 other companies have achieved higher Revenue growth. While Erba Diagnostics, Inc.' s Revenue growth of 13.66% ranks overall at the positon no. 3131 in the first quarter 2014.
Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014
Erba Diagnostics,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
5.82 %
-5.85 %
-19.25 %
(Jun 30 2011)
IVD's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2014 Erba Diagnostics, Inc. disclosed fall in Revenue from the fourth quarter by -19.25% to $ 4.85 millions, from $ 6.01 millions achived in the previous reporting period.
Although periodic circumstance commonly energize I. Quarter 2014 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.
Within Laboratory Analytical Instruments industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Erba Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3885.
In the I. Quarter 2014 Erba Diagnostics, Inc. disclosed fall in Revenue from the fourth quarter by -19.25% to $ 4.85 millions, from $ 6.01 millions achived in the previous reporting period.
Although periodic circumstance commonly energize I. Quarter 2014 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.
Within Laboratory Analytical Instruments industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Erba Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3885.
Erba Diagnostics,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2014)
12 Months Ending (Jun 30 2014)
12 Months Ending (Mar 31 2012)
12 Months Ending (Dec 31 2011)
12 Months Ending
Cumulative Revenue 12 Months Ending
$ 27.01
$ 0.00
$ 0.00
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
14.33 %
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
# 1107
# 982
# 0
# 0
# 0
Seqeuential Revenue Change (TTM)
-15.03 %
-
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 3131
# 2621
# 0
# 0
# 0
Cumulative Revenue growth Comment
With 14.33% annual Revenue growth, Erba Diagnostics, Inc. would report a record annual Revenue increase if the fiscal year would end on Sep 30 2014.
In the Healthcare sector 144 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 982 to 1107.
With 14.33% annual Revenue growth, Erba Diagnostics, Inc. would report a record annual Revenue increase if the fiscal year would end on Sep 30 2014.
In the Healthcare sector 144 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 982 to 1107.
About Erba Diagnostics, Revenue Growth Rates (IVD), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.